chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1. Slight soreness around injection site starting around 6 hours after injection. Lasted about one day. No treatment needed.  2. Light headed starting around 8 hours after injection and lasted only a few hours. No treatment needed. 3. Headache starting around 8 hours after injection and lasted about 1.5 days. No treatment. 3. Strong lethargy starting about 12 hours after injection and lasting about 2 days. Lethargic enough that I had to take a day out of work. No treatment. 4. Flare up of what looks like plaque psoriasis on scalp and on face starting about 5 days after FIRST injection on 02/20/2021. Ongoing. No treatment yet.
Pt says after about 2 hours she had a seizure, she went to ER and stayed in hospital overnight. Pt also states head, face is swollen and she was flourescent red all over for about 20 hours.
The day after her second dose she became very confused. Tried to make a phone call with the tv remote and couldn't remember how to turn on tv. (Prior to this, neither of these have been a problem). She thought her recliner was the toilet, pulled her pants down and urinated. She tried to do this again later that night.  Next morning she had no recollection of doing this and seemed much less confused.
Raised papule, erythema at site of VARICELLA vaccination, Approx 3cm X 4 cm.
Patient reports following symptoms that started around 2 weeks after immunization with zostavax. She received PREVNAR 13 on 5/19/17 but she does not attribute the symptoms to the PREVNAR 13. She described pins and needles feelings or electric shocks from wrist to elbow. She describes pain as if she were bruised (but not actually bruised) from elbow to shoulder. Muscle at shoulder "catches" and knots up. The right arm has been weak. Recently she started similar symptoms in the left arm but saw Dr.  who says that he sees symptoms like this frequently from ZOSTAVAX immunizations. He treated her with steroids and the left arm is much better. This summer she spent time in a rehab for the wound on her hip that wasn't healing well. I do not believe that she thinks this is related to the immunization at all.
Itchy rash on back, legs, arms. Joint pain, headache, sore throat, nausea, fatigue. Onset of symptoms 2/1/19 at 7:00 PM; other symptoms were present when patient woke up on morning of 2/2/19.
Extreme bloating in abdomen, abdominal pain, heavy vomiting, diarrhea, pain at injection site.
Date of delivery is December, 9pm I woke up from my sleep in 120s my heartbeat, 100 to 168 was heartbeat and couldn't even go to the stores, exertion and shortness of breath, palpitations and light headedness. Urgent care on 9/28/2021 they took my vital and must be a side effect of the vaccine - high heart rate. Had COVID-19 after 1st dose in Aug2021 - I had shortness of breath, fever, Diarrhea, congestion - recovered but have chronic headaches in the past month and went to doctors for that.
This spontaneous report as received from a physician via a company representative refers to 3 patients of unknown age and gender. No pertinent medical history or drug reactions/allergies were provided. On an unknown date, the patients were vaccinated with ZOSTAVAX vial, dose/frequency reported as "as directed" (route and lot number not provided). No co-suspect or concomitant therapies were reported. The physician reported that he had like 3 patients who developed shingles about a year or two after getting the ZOSTAVAX, but they seemed pretty mild (dates not specified). The physician reported that he "thought antivirals" as treatment for these events. The patients sought medical attention by talking with the physician. At the time of the report, the outcome for the patients was reported as recovered/resolved (dates unspecified). Additional information is not expected.
Both ears felt plugged, "terrible" earache in left ear; achy, sweaty, clammy, vomiting a few times; all the night of vaccination.
Side affects experienced 1 week after 2nd dose and again at week 3. Side affects experienced, headache, exhaustion, Chills, flushed skin, body aches.  Side effects last 24-36 hrs before ending. Flushing has been transient, coming and going since 2nd dose.
The following Am pt had elevated temp of 101 az & 3-4 episodes of vomiting; pt was alert & not pale; This reaction lasted for <24 hrs;
Nausea and vomiting. Started 3 days after first dose and became severe after second dose; Nausea and vomiting. Started 3 days after first dose and became severe after second dose; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  A 29-year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 31Mar2021 13:00 (Lot number: ER8732) at the age of 29 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Anxiety" (unspecified if ongoing); "gastritis" (unspecified if ongoing). Concomitant medication(s) included: ALPRAZOLAM. Past drug history included: Clindamycin, reaction(s): "Known allergies: Clindamycin".  The following information was reported: NAUSEA (non-serious), VOMITING (non-serious) all with onset 03Apr2021 14:30, outcome "unknown" and all described as "Nausea and vomiting. Started 3 days after first dose and became severe after second dose". Therapeutic measures were not taken as a result of nausea, vomiting.  Additional information: Patient not had other vaccine in four weeks. Patient had Alprazolam as other medications in two weeks.  No follow-up attempts are possible. No further information is expected.
Broke-out into hives with wheals. Itching. Going on day 7 now of symptoms.
1 day after vaccine: severe body aches. AM of day 2. Pt. awoke with a swollen tongue "twice the size as normal". No difficulty breathing. Parents took pt. to ER where she received PO BENADRYL and PO Prednisone. Was sent home with prescription of 5 day course of Prednisone.
received my 3rd Moderna vaccine yesterday and my armpit is tender; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (received my 3rd Moderna vaccine yesterday and my armpit is tender) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Sep-2021, the patient experienced AXILLARY PAIN (received my 3rd Moderna vaccine yesterday and my armpit is tender). At the time of the report, AXILLARY PAIN (received my 3rd Moderna vaccine yesterday and my armpit is tender) outcome was unknown.            No treatment medications were provided.  No concomitant medications were provided.  Patient  received 3rd Moderna vaccine yesterday, which resulted in tender armpit and enquiring whether that was normal? or not and denied to be followed by safety   Reporter did not allow further contact
Woke up with headache, fatigue, body aches, low-grade fever about 14 hrs after vaccination
Jansen COVID-19 Vaccine EUA.  Severe headache about 4 hours later, fatigue, muscle aches, chills 6 hours after vaccination. Muscle aches, fatigue, chills on and off but especially at night for 3 days.
A patient at local Healthcare was administered a second booster of Moderna rather than an intended second booster of Pfizer. This occurred during a mobile vaccine clinic event.    The vaccine team noticed the error when their charts did not match inventory records. At the time of discovery, multiple patients had received immunizations and the individual affected could not be identified. 21 Patients were vaccinated at this Healthcare Clinic on 6/1/2022.   Addendum  Patient information in requested fields for this VAERS report were entered with filler information(Not assigned to any individual) as the patient is unknown.
heart pain, shortness of breath, fatigue, heart palpitations, fluttering SVT, PVC's, multiple emergency room visits, urgent care, racing heart at rest of 214 beats per minute..... This lasted for roughly 5 weeks after the first symptoms.  I experienced these daily all day long.
Upon check-in the patient presented and reported he was due for a Pfizer vaccine.  The patient confirmed in the exam room prior to vaccine administration he was presenting for his 2nd Pfizer.  The Pfizer vaccine was counseled and fact sheet provided.  After administration of the vaccine it was discovered that the patient had received Moderna, not Pfizer, as the first dose.
Arm Swelling from pneumonia shot went to Hospital was given Solu Medrol and Benadryl for reaction and they may have already reported this event to you but want to be sure.
diagnosis with upper respiratory tract infection; he came down with cold; sore throat; congestion/stuffy nose and head; This is a spontaneous report from a contactable consumer reporting on himself. A 71-year-old male patient received first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, solution for injection) via an unspecified route of administration on an unspecified date (Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Approximately an unspecified date in 2021, (reported as on Thursday), the patient came down with cold, sore throat, congestion, stuffy nose and head, went to emergency room (ER) and the patient was diagnosis with upper respiratory tract infection and his temperature is 98.1. On an unspecified date in 2021, the patient was tested with COVID but not detected. Caller stated he was scheduled to get his second dose today in 3 hours. Caller wanted to know should he take his section dose today. The outcome of the events was unknown. Information on the lot/batch number has been requested.
Patient missed second dose of Moderna vaccine due to having had ankle surgery. Patient stated she would not be able to stand in line to get dose; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient missed second dose of Moderna vaccine due to having had ankle surgery. Patient stated she would not be able to stand in line to get dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Ankle operation.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient missed second dose of Moderna vaccine due to having had ankle surgery. Patient stated she would not be able to stand in line to get dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient missed second dose of Moderna vaccine due to having had ankle surgery. Patient stated she would not be able to stand in line to get dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No  concomitant medical  provided by the reporter. No treatment information provided by the reporter.
Guardian stated patient complained of having more pain than usual, and irritation and burning sensation to the vaccine injection site immediately following vaccine administration. Guardian also stated patient has complained on different occasions about irritation and burning to the vaccine site.
prolonged headache, dizziness, nausea, body aches, chills, extreme fatigue.   36 hours after vaccine, I fainted. Oxygen dropped to 83 (I have an oximeter.)
the day after my second vaccine, my mouth started hurting really bad. I have little blisters all around the circumference of my tongue and on top of it. blisters on my gums and inside of my upper and lower lip. two days after the vaccine the blisters are worse than the day before and I am unable to eat or drink normally. i have probably ate less than one whole meal in 24 hours and drank maybe one glass of water.
Information has been received from a nurse referring to multiple unknown patients of unknown age and gender. Information about pertinent medical history and drug allergies was not provided. On multiple unspecified dates, multiple unknown patients were administered improperly stored VAQTA (lot# M027879, expire date: 24-JAN-2018, dose and frequency were unknown) for prophylaxis. The temperature of storage for VAQTA was 22 Celsius for 5 minutes. This alarm happened while plugging in the Data logger. No adverse effects reported. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1612USA004315: US-009507513-1612USA004316: US-009507513-1612USA004317: US-009507513-1612USA004318.
The day after the injection his skin became flushed all over and he said he felt like he was on fire from the inside. He felt loss of energy and sick. The worst problem though is that within a couple weeks he started having diabetic symptoms when he had never had diabetes or symptoms before. His glucose was checked at 3 weeks and was in the 300's so he went to a primary care dr and was put on metformin. At 6 weeks he had lost about 40 lbs and started having trouble eating and drinking as his blood sugar remained very high. At 8 weeks he was in DKA in the ICU at the hospital. He was then on insulin and type 1 diabetic. It was a hard to control Type 1 and was in Dka 2 more times that year. He passed away 2/27/22. We are still waiting for the final report of his autopsy to know the cause of death, but even if the cause of death isn't related to his diabetes, he still seems to have become a type 1 diabetic within 2 months of the JJ covid vaccine. I am not sure if his endocrinologist ever reported this. His endocrinologist told him that it did appear he had an extreme immune response suddenly that caused his pancreas to stop producing insulin. There may be a genetic factor as I had pancreatic cancer at the age of 36 as did my grandmother at 48. I also have hashimotos as does his sister and grandfather and paternal aunt. I do not have all of his Dr. info as he lived in (Privacy) and I am in (Privacy) and he is now deceased. The medical examiner is in the (Privacy) office in (Privacy) and their number is (Privacy). My liver enzymes went very high for 3 months after I received the covid vaccine too. I am not sure about my sons.
Information has been received from a physician concerning a 43 year old male who on 09/24/01 was revaccinated with a dose of MMR II in the left arm (lot 635180/0737L). On 10/04/01, the pt developed a rash and fever. On 10/09/01, the pt developed a diffuse maculopapular rash and "vaccine induced" measles rash. The pt sought unspecified medical attention. The pt had only a physical exam. Subsequently, the pt recovered. No additional info is expected.
Rash back; Hot to the touch injection site; Sore arm; Red injection site; Rash in injection site small dinner plate size; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to the touch injection site), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Red injection site), VACCINATION SITE RASH (Rash in injection site small dinner plate size) and VACCINATION SITE RASH (Rash back) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, the patient experienced VACCINATION SITE WARMTH (Hot to the touch injection site), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE RASH (Rash in injection site small dinner plate size). On 04-May-2021, the patient experienced VACCINATION SITE RASH (Rash back). On 22-Apr-2021, VACCINATION SITE WARMTH (Hot to the touch injection site), VACCINATION SITE PAIN (Sore arm), VACCINATION SITE ERYTHEMA (Red injection site) and VACCINATION SITE RASH (Rash in injection site small dinner plate size) had resolved. At the time of the report, VACCINATION SITE RASH (Rash back) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The reporter was calling on behalf of their daughter who received their first Moderna vaccine and experienced sore arm, red and hot to touch injection site and rash in injection site small dinner plate size for 3 days.   Reportedly, on 04-May-2021 the rash appeared back.  No Concomitant product use was reported. No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-109778 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-109778:Reporter's case
Fever, red non raised rash, swollen tonsils. Fever started 7/27/16 and ended 7/28/16. Red rash and swollen tonsils started 7/29/16.
Pt came in for a flu shot but got 4th Covid-19 moderna shot. Patient previously got the 3rd dose 2 weeks prior 8/14th
Weak, chest pains, low blood pressure, fast heart rate, shakes, low grade fever, body aches.
This spontaneous report as received from a physician refers to a female patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL (dose, route and lot number not provided). Subsequently, on an unknown date, the patient developed HPV disease. The outcome of the event was unknown. The causal relationship was not reported. Additional information has been requested.
Breast cancer; This spontaneous case was reported by a consumer and describes the occurrence of BREAST CANCER (Breast cancer) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) for Plaque psoriasis.    Concurrent medical conditions included Plaque psoriasis.   On 09-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Jan-2021, the patient started RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) at an unspecified dose. On 09-Dec-2021, RISANKIZUMAB (SKYRIZI [RISANKIZUMAB]) (Subcutaneous) dosage was changed to at an unspecified dose. In March 2022, the patient experienced BREAST CANCER (Breast cancer) (seriousness criterion medically significant). At the time of the report, BREAST CANCER (Breast cancer) had not resolved.            This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in  Concomitant medications were not reported.  It was unknown if patient was enrolled in a covid-19 vaccine trial. On 22 Mar 2022 patient saw her physician to discuss. Physician instructed to hold her next dose of Skyrizi to had a better understanding of the treatment plan for breast cancer. Treatment medications were not reported.  The reporter's causality for the event(s) of breast cancer was not provided. Abbvie's opinion is that there is no reasonable possibility that the event of breast cancer is related to Skyrizi (risankizumab).  Company Comment: This is a spontaneous case concerning a 57-year-old female patient with no relevant medical history, who experienced the unexpected, serious (medically significant) event of Breast cancer, approximately 14 months after receiving the second dose of mRNA-1273 vaccine. Clinical course, diagnostic tests and treatment details were not provided in the case. The event had not resolved at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This is a spontaneous case concerning a 57-year-old female patient with no relevant medical history, who experienced the unexpected, serious (medically significant) event of Breast cancer, approximately 14 months after receiving the second dose of mRNA-1273 vaccine. Clinical course, diagnostic tests and treatment details were not provided in the case. The event had not resolved at the time of the report. The benefit-risk relationship of mRNA-1273 is not affected by this report.
itchy, red, hard, induration @ inj site;tender, warm to touch;area 5x10cm;
Vomiting/diarrhea. Red, swelling to injection site. Felt hot to injection site. Treatment for cellulitis was given.
Immunization given 5/3/06 noticed redness on left shoulder. C/O pain unable to lift arm.
about a week after taking 1st dose of covid vax her left knee became stiff and painful with swelling.   She has been applying ice and taking Tylenol which seems to help but has had these symptoms going on 3 weeks.  She recently had her 2nd dose on 4/21/21 with no reactions but continues to have swelling and pain in her left knee.
Expired Rotarix (lyo) was administered to patient on 14JUL2023; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a male patient who received Rota (Rotarix lyophilized formulation) (batch number G973H, expiry date 01-JUL-2023) for prophylaxis.   On 14-JUL-2023, the patient received Rotarix lyophilized formulation. On 14-JUL-2023, an unknown time after receiving Rotarix lyophilized formulation, the patient experienced expired vaccine used (Verbatim: Expired Rotarix (lyo) was administered to patient on 14JUL2023). The outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date 18 Jul 2023: The HCP reported that Expired Rotarix (lyo) was administered to patient which led to expired vaccine used. The reporter consented to follow up.
This spontaneous report has been received from a registered nurse referring to a 26 month old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not provided. On 28-DEC-2016, the patient was vaccinated with a dose of GARDASIL 9, intramuscular, (dose, anatomical location and frequency were not provided)  lot # M024261, with an expiration date of 30-JUL-2018 for prophylaxis. No known adverse effects were reported. Additional information has been requested.
Left arm swollen post injection with fever. Left arm 12" in diameter. Right arm unaffected - 11" in diameter. Headache on left side of her head, directly above her eye.
After both vaccines developed fever of 102, migraine headaches, extreme body aches for two days.  Lingering headaches and diarrhea continue.  Diagnosed with Covid on December 31, 2020.
A spontaneous report was received on 19JUN2015 from a pharmacist via a company representative regarding an approximately 65 year old female who received ZOSTAVAX 0.65 ml subcutaneous in JAN2015. The pharmacist reported that the patient developed cellulitis on her "entire upper arm at the injection site" (arm unspecified) "within a few days of receiving ZOSTAVAX" (unspecified as to what facility/provider gave the ZOSTAVAX). It was reported the patient sought medical attention when she "informed an unspecified pharmacist an unspecified way on an unspecified date". No further information was provided. Additional information has been requested.
Fever  Cough  Fatigue  Muscle or body aches  Elevated BP Shortness of breath Congestion or running nose
PATIENT RECEIVED PFIZER VACCINE THAT WAS NOT STORED EXACTLY PER MANUFACTURERS RECOMMENDATIONS (2-3 DAYS PAST THE EXPIRATION DATE).  PATIENT WAS RECOMMENDED TO REPEAT THE VACCINE BUT SHE HAD A STRONG IMMUNE RESPONSE AFTER HER VACCINE AND DID NOT WISH TO REPEAT THE VACCINE UNTIL HER SECOND DOSE IS DUE.
Patient first experienced a fever the day after and then had a red spot on her arm which has gotten bigger over the past 10 days .  The size of the red spot is about the size of her hand.
Severe thrombocytopenia with hematuria.  Improved with transfusion.  Primary suspicion is for drug-induced thrombocytopenia due to antibiotics.